References
Bank A, Larsen PR, Anderson HM (1966) Di Guglielmo’s syndrome after polycythemia. N Engl J Med 275:489–490. https://doi.org/10.1056/NEJM196609012750908
Blum S, Angelillo-Scherrer A (2012) Block of red blood cell maturation in acute erythroid leukemia. Blood 120:1974
Brada SJ, de Wolf JT, Poppema S, Vellenga E (1998) Ischaemic colitis and lung infiltrates caused by extramedullary haematopoiesis in a patient with an acute erythroid leukaemia following polycythaemia vera. Neth J Med 52:142–146
Eastman P, Wallerstein RO, Schrier SL (1968) Conversion of polycythemia vera to chronic Di Guglielmo’s syndrome. JAMA 204:1141–1143
Li H, Hasserjian RP, Kroft SH, Harrington AM, Wheaton SE, Pildain A, Ewalt MD, Gratzinger D, Hosking P, Olteanu H (2016) Pure erythroid leukemia and erythroblastic sarcoma evolving from chronic myeloid neoplasms. Am J Clin Pathol 145:538–551. https://doi.org/10.1093/ajcp/aqw033
Pezzimenti JF, Kim HC, Lindenbaum J (1976) Erythroleukemia-like syndrome due to busulfan toxicity in polycythemia vera. Cancer 38:2242–2246
Santos FP, Bueso-Ramos CE, Ravandi F (2010) Acute erythroleukemia: diagnosis and management. Expert Rev Hematol 3:705–718. https://doi.org/10.1586/ehm.10.62
Santos FP, Faderl S, Garcia-Manero G, Koller C, Beran M, O’Brien S, Pierce S, Freireich EJ, Huang X, Borthakur G, Bueso-Ramos C, de Lima M, Keating M, Cortes J, Kantarjian H, Ravandi F (2009) Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia 23:2275–2280. https://doi.org/10.1038/leu.2009.181
Scott RB, Ellison RR, Ley AB (1964) A clinical study of twenty cases of erythroleukemia (Di Guglielmo’s syndrome). Am J Med 37:162–171
Stein BL, Moliterno AR, Tiu RV (2014) Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment options. Ann Hematol 93:1965–1976. https://doi.org/10.1007/s00277-014-2205-y
Tallarico M, Odenike O (2015) Secondary acute myeloid leukemias arising from Philadelphia chromosome negative myeloproliferative neoplasms: pathogenesis, risk factors, and therapeutic strategies. Curr Hematol Malig Rep 10:112–117. https://doi.org/10.1007/s11899-015-0259-0
Tefferi A, Barbui T (2015) Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management. Am J Hematol 90:162–173. https://doi.org/10.1002/ajh.23895
Wang SA, Hasserjian RP (2012) Erythroid proliferations in myeloid neoplasms. Hum Pathol 43:153–164. https://doi.org/10.1016/j.humpath.2011.08.008
Wang SA, Hasserjian RP (2015) Acute erythroleukemias, acute megakaryoblastic leukemias, and reactive mimics: a guide to a number of perplexing entities. Am J Clin Pathol 144:44–60. https://doi.org/10.1309/AJCPRKYAT6EZQHC7
Zuo Z, Polski JM, Kasyan A, Medeiros LJ (2010) Acute erythroid leukemia. Arch Pathol Lab Med 134:1261–1270. https://doi.org/10.1043/2009-0350-RA.1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Ware, A.D., Birkness, J., Duffield, A.S. et al. Molecular evidence of JAK2 p.V617F mutated pure erythroid leukemia arising from polycythemia vera. Virchows Arch 473, 131–135 (2018). https://doi.org/10.1007/s00428-018-2347-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-018-2347-8